المؤلفون: Brivio E; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Pennesi E; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Willemse ME; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Huitema ADR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; The Netherlands Cancer Institute, Amsterdam, the Netherlands.; University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Jiang Y; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Tinteren HDR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Beverloo BH; Department of Clinical Genetics, Erasmus MC, Rotterdam, the Netherlands., den Boer ML; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Rammeloo LAJ; Department of Pediatric Cardiology, Amsterdam UMC, Emma Children's Hospital, Amsterdam, the Netherlands., Hudson C; Hematologics Inc, Seattle, WA., Heerema N; Nationwide Children's Hospital, Columbus, OH., Kowalski K; Pfizer Inc, New York, NY., Zhao H; Pfizer Inc, New York, NY., Kuttschreuter L; Pfizer Inc, New York, NY., Bautista Sirvent FJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Pediatric Oncology and Hematology Department, Hospital Niño Jesús, Madrid, Spain., Bukowinski A; Pediatric Hematology and Oncology Alabama, University of Alabama at Birmingham, Birmingham, AL., Rizzari C; Department of Pediatrics, University of Milano-Bicocca, IRCCS San Gerardo dei Tintori, Monza, Italy., Pollard J; Dana-Farber/Harvard Cancer Center, Boston, MA., Murillo-Sanjuán L; Hospital Universitari Vall d'Hebron, Barcelona, Spain., Kutny M; Children's Hospital of Alabama, Birmingham, AB., Zarnegar-Lumley S; Vanderbilt University, Nashville, TN., Redell M; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Cooper S; Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD., Bertrand Y; CHU Lyon, Hospices Civils de Lyon, Lyon, France., Petit A; Hôpital Armand Trousseau, Paris, France., Krystal J; The Steven and Alexandra Cohen Children's Medical Center of New York, New York, NY., Metzler M; Universitätsklinikum Erlangen, Erlangen, Germany., Lancaster D; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Bourquin JP; University Children's Hospital, Zürich, Switzerland., Motwani J; Birmingham Children's Hospital, Birmingham, United Kingdom., van der Sluis IM; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Locatelli F; IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy., Roth ME; University of Texas MD Anderson Cancer Center, Houston, TX., Hijiya N; Columbia University Irving Medical Center, New York, NY., Zwaan CM; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Mar 01; Vol. 42 (7), pp. 821-831. Date of Electronic Publication: 2023 Nov 30.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/adverse effects , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy , Leukemia, Myeloid, Chronic-Phase*/drug therapy , Quinolines*/adverse effects, Adolescent ; Adult ; Child ; Child, Preschool ; Humans ; Infant ; Aniline Compounds/adverse effects ; Nitriles/adverse effects ; Protein Kinase Inhibitors/adverse effects ; Treatment Outcome